Literature DB >> 12933405

Antinociceptive properties of neurosteroids: a comparison of alphadolone and alphaxalone in potentiation of opioid antinociception.

L Winter1, R Nadeson, A P Tucker, C S Goodchild.   

Abstract

In this study, we investigated the antinociceptive and sedative effects of the opioids fentanyl, morphine, and oxycodone given alone and in combination with two neurosteroids: alphadolone and alphaxalone. An open-field activity monitor and rotarod apparatus were used to define the sedative effects caused by opioid and neurosteroid compounds given alone intraperitoneally to male Wistar rats. Dose-response curves for antinociception were constructed using only nonsedative doses of these drugs. At nonsedating doses, fentanyl, morphine, and oxycodone all caused dose-dependent tail flick latency (TFL) antinociceptive effects. Because neither neurosteroid altered TFL, electrical current was used as the test to determine doses of neurosteroid that caused antinociceptive effects at nonsedative doses. Alphadolone 10 mg/kg intraperitoneally caused significant antinociceptive effects in the electrical test but alphaxalone did not. All three opioid dose-response curves for TFL antinociception were shifted to the left by coadministration of alphadolone even though alphadolone alone had no effect on TFL. Alphaxalone given alone had no antinociceptive effects at nonsedative doses and it had no effect on opioid antinociception. Neither neurosteroid caused sedative effects when combined with opioids. We conclude that coadministration of alphadolone, but not alphaxalone, with morphine, fentanyl, or oxycodone potentiates antinociception and that this effect is not caused by an increase in sedation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933405     DOI: 10.1213/01.ane.0000075835.73967.f3

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  10 in total

Review 1.  Neurogenic pain and steroid synthesis in the spinal cord.

Authors:  Christine Patte-Mensah; Cherkaouia Kibaly; Domitille Boudard; Véronique Schaeffer; Aurélie Béglé; Simona Saredi; Laurence Meyer; Ayikoe G Mensah-Nyagan
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Neurosteroids and self-reported pain in veterans who served in the U.S. Military after September 11, 2001.

Authors:  Jason D Kilts; Larry A Tupler; Francis J Keefe; Victoria M Payne; Robert M Hamer; Jennifer C Naylor; Rohana P Calnaido; Rajendra A Morey; Jennifer L Strauss; Gillian Parke; Mark W Massing; Nagy A Youssef; Lawrence J Shampine; Christine E Marx
Journal:  Pain Med       Date:  2010-08-23       Impact factor: 3.750

3.  Discovery of a Potent Analgesic NOP and Opioid Receptor Agonist: Cebranopadol.

Authors:  Stefan Schunk; Klaus Linz; Claudia Hinze; Sven Frormann; Stefan Oberbörsch; Bernd Sundermann; Saskia Zemolka; Werner Englberger; Tieno Germann; Thomas Christoph; Babette-Y Kögel; Wolfgang Schröder; Stephanie Harlfinger; Derek Saunders; Achim Kless; Hans Schick; Helmut Sonnenschein
Journal:  ACS Med Chem Lett       Date:  2014-06-24       Impact factor: 4.345

4.  Discovery of Spiro[cyclohexane-dihydropyrano[3,4-b]indole]-amines as Potent NOP and Opioid Receptor Agonists.

Authors:  Stefan Schunk; Klaus Linz; Sven Frormann; Claudia Hinze; Stefan Oberbörsch; Bernd Sundermann; Saskia Zemolka; Werner Englberger; Tieno Germann; Thomas Christoph; Babette-Y Kögel; Wolfgang Schröder; Stephanie Harlfinger; Derek Saunders; Achim Kless; Hans Schick; Helmut Sonnenschein
Journal:  ACS Med Chem Lett       Date:  2014-06-24       Impact factor: 4.345

5.  Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: a potential component of nociception.

Authors:  Christine Patte-Mensah; Cherkaouia Kibaly; Ayikoe G Mensah-Nyagan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-10       Impact factor: 11.205

6.  Are neuroactive steroids promising therapeutic agents in the management of acute and chronic pain?

Authors:  Vesna Jevtovic-Todorovic; Douglas F Covey; Slobodan M Todorovic
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

7.  GABAA and glycine receptor-mediated transmission in rat lamina II neurones: relevance to the analgesic actions of neuroactive steroids.

Authors:  Elizabeth A Mitchell; Luc J Gentet; John Dempster; Delia Belelli
Journal:  J Physiol       Date:  2007-07-26       Impact factor: 5.182

8.  The clinical measurement, measurement method and experimental condition ontologies: expansion, improvements and new applications.

Authors:  Jennifer R Smith; Carissa A Park; Rajni Nigam; Stanley Jf Laulederkind; G Thomas Hayman; Shur-Jen Wang; Timothy F Lowry; Victoria Petri; Jeff De Pons; Marek Tutaj; Weisong Liu; Elizabeth A Worthey; Mary Shimoyama; Melinda R Dwinell
Journal:  J Biomed Semantics       Date:  2013-10-08

9.  Electrophysiological characterisation of central sensitisation in canine spontaneous osteoarthritis.

Authors:  James R Hunt; Megan Goff; Helen Jenkins; John Harris; Toby G Knowles; B Duncan X Lascelles; Masataka Enomoto; Michael Mendl; Helen R Whay; Joanna C Murrell
Journal:  Pain       Date:  2018-11       Impact factor: 7.926

10.  Alfaxalone improved in acute stress-induced tactile hypersensitivity and anxiety-like behavior in mice.

Authors:  Kazumi Yoshizawa; Saki Ukai; Junpei Kuroda; Tsugumi Yamauchi; Daisuke Yamada; Akiyoshi Saitoh; Satoshi Iriyama; Shoichi Nishino; Satoru Miyazaki
Journal:  Neuropsychopharmacol Rep       Date:  2022-02-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.